Latest Options News

Page 299 of 509
The Calmer Co. has secured a long-term lease for its Navua facility in Fiji, replacing a planned property purchase and freeing up capital to accelerate its US market expansion.
Victor Sage
Victor Sage
8 Aug 2025
American West Metals has launched an offer of over 104 million new options to select investors and advisors, potentially raising $6.28 million upon exercise. The move aims to enhance liquidity and support ongoing exploration projects.
Maxwell Dee
Maxwell Dee
8 Aug 2025
AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.
Ada Torres
Ada Torres
8 Aug 2025
Astute Metals NL has successfully completed the first tranche of its capital raising, issuing over 92 million shares and securing $1.39 million before costs. The company is preparing to close a second tranche involving key directors and sophisticated investors.
Maxwell Dee
Maxwell Dee
8 Aug 2025
X2M Connect Limited has completed a $309,000 entitlement offer by issuing 23.76 million new shares and options, while a substantial shortfall of nearly 127 million shares remains available for placement.
Sophie Babbage
Sophie Babbage
8 Aug 2025
Magnetite Mines Limited has announced a pro rata renounceable rights issue aiming to raise up to $2.65 million to advance its flagship Razorback iron ore project. The capital raise includes free attaching options and is partially underwritten, supporting key development milestones and strategic partnerships.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Magnetite Mines Limited has announced a renounceable rights issue to raise up to $2.65 million, aiming to fund critical development milestones for its Razorback Iron Ore Project and secure strategic partnerships for DFS funding.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Neuren Pharmaceuticals has added SYNGAP1-related disorder to its NNZ-2591 development program following encouraging pre-clinical findings, targeting a rare condition with no approved treatments.
Ada Torres
Ada Torres
8 Aug 2025
PYC Therapeutics has escalated dosing to the highest level in its Phase 1a trial of PYC-003 and begun dosing patients with Polycystic Kidney Disease, marking key progress toward regulatory milestones.
Ada Torres
Ada Torres
8 Aug 2025
Pinnacle Minerals Limited has launched a new options prospectus offering nearly 40 million options, potentially raising $3.18 million if exercised. The options carry an exercise price of $0.08 and expire in 2028, aiming to reward shareholders and fulfill placement obligations.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Novo Resources Corp reported a reduced net loss of CAD 5.85 million for H1 2025, improving liquidity while continuing its gold exploration efforts in Australia.
Maxwell Dee
Maxwell Dee
8 Aug 2025
QBE Insurance Group has announced a 31-cent ordinary dividend for the half-year ending June 2025, offering shareholders multiple currency payment options and participation in dividend reinvestment and bonus share plans.
Victor Sage
Victor Sage
8 Aug 2025